Table of Content

1. Executive Summary
   1. Global MRNA Therapeutics Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Tool Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
   1. Key Highlights
   2. Key Factors Impacting Deployment Costs
   3. Pricing Analysis, By Application
5. Global MRNA Therapeutics Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
   3. Global MRNA Therapeutics Market Outlook: Product Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
         1. Therapeutic mRNA Vaccines
         2. Therapeutic mRNA Proteins
         3. Prophylactic Vaccines
         4. Therapeutic Drugs
         5. Others
      4. Market Attractiveness Analysis: Product Type
   4. Global MRNA Therapeutics Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
         1. Oncology
         2. Infectious Diseases
         3. Rare Genetic Diseases
         4. Respiratory Diseases
         5. Cardiovascular & Metabolic Disorders
         6. Others
      4. Market Attractiveness Analysis: Application
   5. Global MRNA Therapeutics Market Outlook: Delivery System
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Delivery System, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025 - 2032
         1. Lipid Nanoparticles (LNPs)
         2. Polymeric Nanoparticles
         3. Others
      4. Market Attractiveness Analysis: Delivery System
6. Global MRNA Therapeutics Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America MRNA Therapeutics Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Application
      4. By Delivery System
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Therapeutic mRNA Vaccines
      2. Therapeutic mRNA Proteins
      3. Prophylactic Vaccines
      4. Therapeutic Drugs
      5. Others
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Infectious Diseases
      3. Rare Genetic Diseases
      4. Respiratory Diseases
      5. Cardiovascular & Metabolic Disorders
      6. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025-2032
      1. Lipid Nanoparticles (LNPs)
      2. Polymeric Nanoparticles
      3. Others
   7. Market Attractiveness Analysis
8. Europe MRNA Therapeutics Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Application
      4. Delivery System
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Therapeutic mRNA Vaccines
      2. Therapeutic mRNA Proteins
      3. Prophylactic Vaccines
      4. Therapeutic Drugs
      5. Others
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Infectious Diseases
      3. Rare Genetic Diseases
      4. Respiratory Diseases
      5. Cardiovascular & Metabolic Disorders
      6. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025-2032
      1. Lipid Nanoparticles (LNPs)
      2. Polymeric Nanoparticles
      3. Others
   7. Market Attractiveness Analysis
9. East Asia MRNA Therapeutics Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Application
      4. By Delivery System
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Therapeutic mRNA Vaccines
      2. Therapeutic mRNA Proteins
      3. Prophylactic Vaccines
      4. Therapeutic Drugs
      5. Others
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Infectious Diseases
      3. Rare Genetic Diseases
      4. Respiratory Diseases
      5. Cardiovascular & Metabolic Disorders
      6. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025-2032
      1. Lipid Nanoparticles (LNPs)
      2. Polymeric Nanoparticles
      3. Others
   7. Market Attractiveness Analysis
10. South Asia & Oceania MRNA Therapeutics Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Product Type
       3. By Application
       4. By Delivery System
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
       1. Therapeutic mRNA Vaccines
       2. Therapeutic mRNA Proteins
       3. Prophylactic Vaccines
       4. Therapeutic Drugs
       5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
       1. Oncology
       2. Infectious Diseases
       3. Rare Genetic Diseases
       4. Respiratory Diseases
       5. Cardiovascular & Metabolic Disorders
       6. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025-2032
       1. Lipid Nanoparticles (LNPs)
       2. Polymeric Nanoparticles
       3. Others
    7. Market Attractiveness Analysis
11. Latin America MRNA Therapeutics Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Product Type
       3. By Application
       4. By Delivery System
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
       1. Therapeutic mRNA Vaccines
       2. Therapeutic mRNA Proteins
       3. Prophylactic Vaccines
       4. Therapeutic Drugs
       5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
       1. Oncology
       2. Infectious Diseases
       3. Rare Genetic Diseases
       4. Respiratory Diseases
       5. Cardiovascular & Metabolic Disorders
       6. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025-2032
       1. Lipid Nanoparticles (LNPs)
       2. Polymeric Nanoparticles
       3. Others
    7. Market Attractiveness Analysis
12. Middle East & Africa MRNA Therapeutics Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Product Type
       3. By Application
       4. By Delivery System
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
       1. Therapeutic mRNA Vaccines
       2. Therapeutic mRNA Proteins
       3. Prophylactic Vaccines
       4. Therapeutic Drugs
       5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
       1. Oncology
       2. Infectious Diseases
       3. Rare Genetic Diseases
       4. Respiratory Diseases
       5. Cardiovascular & Metabolic Disorders
       6. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery System, 2025-2032
       1. Lipid Nanoparticles (LNPs)
       2. Polymeric Nanoparticles
       3. Others
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Moderna, Inc.
          1. Overview
          2. Segments and Deployments
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Pfizer Inc.
       3. BioNTech SE
       4. CureVac N.V.
       5. Sanofi S.A.
       6. GlaxoSmithKline plc
       7. Arcturus Therapeutics Holdings, Inc.
       8. Providence Therapeutics Holdings Inc.
       9. Ethris GmbH
       10. eTheRNA immunotherapies NV
       11. SINOVAC Biotech Ltd.
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations